Oxidative Deamination
- Compartment
- Mitochondrial matrix
- Main tissue
- Liver, kidney
- Rate-limiting
- Not flagged in the source
- Steps
- 3
Reaction steps
In source order, 3 total
-
1
L-glutamate + NAD⁺ (or NADP⁺) + H₂O ⇌ α-ketoglutarate + NH₄⁺ + NADH (or NADPH) + H⁺
› Notes
Glutamate dehydrogenase catalyzes oxidative deamination in the mitochondrial matrix. NAD⁺ is generally the major oxidant during net hepatic glutamate oxidation, although the enzyme can use NADP⁺; the reaction is reversible and is the principal regulated route for release of free ammonia from glutamate.
-
2
L-glutamine + H₂O → L-glutamate + NH₄⁺
› Notes
Glutaminase hydrolyzes the amide nitrogen of glutamine in mitochondria; it requires water but no redox cofactor. This irreversible hydrolytic deamidation is not itself oxidative deamination, but it is a major upstream source of mitochondrial glutamate and ammonia in liver, kidney, intestine, and brain.
-
3
L-asparagine + H₂O → L-aspartate + NH₄⁺
› Notes
Asparaginase catalyzes irreversible deamidation, providing a smaller additional source of ammonia. The resulting aspartate can be transaminated to oxaloacetate and glutamate or can donate nitrogen to the urea cycle.
Showing all 3 steps.
Regulation
What speeds each enzyme up and what slows it down
Glutamate dehydrogenase
ADP, GDP; leucine allosterically activates the mammalian enzyme
ATP, GTP; high-energy charge
Glucagon and cortisol increase hepatic amino-acid catabolic/ureagenic capacity indirectly; insulin suppresses net amino-acid catabolism in the fed state
Hepatic glutaminase
Glutamine availability; chronic high-protein intake/acidosis can increase expression
Product accumulation; reduced demand for ammonia disposal
Glucagon can support hepatic ureagenic flux; regulation is largely transcriptional and substrate-driven
Renal glutaminase
Acidosis, glutamine availability
Alkalosis reduces net ammoniagenic drive
Cortisol supports renal ammoniagenesis; acid–base status is the dominant physiological regulator
Overview
Oxidative deamination releases the amino nitrogen of glutamate as ammonium while regenerating α-ketoglutarate. In the liver this provides mitochondrial ammonia for carbamoyl phosphate synthesis and the urea cycle; in kidney, ammonium production contributes to acid excretion. Coupling transamination to glutamate dehydrogenase creates the classic transdeamination route by which nitrogen from many amino acids is ultimately disposed of.
Cellular location
Glutamate dehydrogenase (GDH/GLUD) is a mitochondrial matrix enzyme, especially active in liver and kidney and present in brain and other oxidative tissues. Mitochondrial localization places generated NH₄⁺ adjacent to carbamoyl phosphate synthetase I in hepatocytes.
Net energetics
For net GDH oxidation with NAD⁺, one glutamate yields 1 NADH and one NH₄⁺, with no ATP consumed. If NADP⁺ is the acceptor, the reaction yields 1 NADPH instead; subsequent oxidative phosphorylation of NADH can capture energy if reducing equivalents are reoxidized.
Clinical significance
Free ammonia is neurotoxic, so oxidative deamination is tightly coupled to urea synthesis in periportal hepatocytes or to renal ammonium excretion. Activating GLUD1 variants cause hyperinsulinism/hyperammonemia syndrome, partly because leucine-stimulated GDH promotes insulin secretion and excess ammonia generation. Conversely, impaired hepatic ammonia detoxification in severe liver disease produces hyperammonemia and can contribute to hepatic encephalopathy.
Recent literature
Live Europe PMC search
Europe PMC · fetched just now · sorted by publication date
-
1
Systemic Copper Chelation Reduces Collagen Deposition and Preserves Secretory Function in Irradiated Mouse Salivary Glands.
Nam K, Maslow FM, Santos HTD, Shanbhag VC, Osorio RA, Petris MJ, Baker OJ. · 2026-07-22
open access unreviewed -
2
Efficacy of tannins as silage additives to inhibit deamination process during ensiling: a meta-analysis and <i>in silico</i> approach.
Susanto I, Mahendra FR, Azzahra FR, Rahmadani M, Ridwan R, Wiryawan KG, Laconi EB, Jayanegara A. · 2026-06-15
cited 1× open access unreviewed -
3
The nucleus as a mechanobiological hub in muscle aging.
Esen O, Battey E, Stroud MJ, Kirby TJ. · 2026-06-18
cited 1× open access unreviewed -
4
The protease code of the bacterial gut microbiota: ecological regulation, barrier disruption, and rewiring host defense and signaling.
Eckhard U, Ramírez-Larrota JS, Estevan-Morió E, Gomis-Rüth FX. · 2026-06-10
open access unreviewed -
5
Research progress in metabolic reprogramming and targeting metabolic pathways for clear cell renal cell carcinoma.
Yao JT, Hu PC, Li XW, Xu JC, Wang KJ, Ye SZ, Meng XY, Chen HC, Liang Y, Ma Q. · 2025-12-19
open access unreviewed -
6
Iron and Other Metal Ions in Human Health and Disease.
Dai X, Li J. · 2026-10-02
open access unreviewed -
7
Exploring the Neuropharmacological Potential of Ligustrum sinense Relevant to Parkinson's Disease: In Vivo and In Silico Study.
Das S, Hamim SMI, Zilani MNH, Chhando KS, Das P, Hossain MR, Imtiaz M, Tasmin J, Miah R, Hasan MN. · 2026-10-01
open access unreviewed -
8
Glutamine Metabolism in Health and Diseases.
Ding Y, Tong F, Zeng J, Cui CP. · 2026-09-29
open access unreviewed -
9
Two distinct alcohol dehydrogenase classes mediate bacterial 2-hydroxyethylphosphonate catabolism.
Piazza F, Rodella M, Salanti N, Merici G, Rossi E, Rivetti C, Götzinger F, Pallitsch K, Peracchi A. · 2026-10-01
cited 1× open access unreviewed -
10
An Integrated in Silico, in Vitro, and in Vivo Assessment of the Antioxidant and Neuroprotective Profile of Selenocyanate Compounds.
da Rocha MER, Pizzi BR, da Costa P, Hall TK, Paim MP, Cordeiro P, Menezes V, Nascimento V, Brüning CA, Birman… · 2026-07-31
open access unreviewed
External claims. These come from an index outside this database and are not checked against it. Treat them as leads.